Seegene, Inc. (KOSDAQ: 096530)

Market Cap	1.03T
Revenue (ttm)	382.48B
Net Income (ttm)	23.13B
Shares Out	46.21M
EPS (ttm)	499.76
PE Ratio	44.42
Forward PE	40.96
Dividend	800.00 (3.63%)
Ex-Dividend Date	Sep 27, 2024

Volume	262,369
Open	21,750
Previous Close	22,000
Day's Range	21,600 - 22,350
52-Week Range	19,500 - 35,950
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Seegene

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis de...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2000
• Employees: 63
• Stock Exchange: KOSDAQ
• Ticker Symbol: 096530

Financial Performance

In 2023, Seegene's revenue was 367.38 billion, a decrease of -56.96% compared to the previous year's 853.56 billion. Earnings were 669.01 million, a decrease of -99.63%.